title: For type 2 diabetes poorly controlled by metformin monotherapy, the addition of any non-insulin antidiabetic drug reduces HbA1c to a similar extent, but with differing effects on weight and hypoglycaemic risk.
authors.affiliation: Heartlands Biomedical Research Centre. srikanth.bellary@heartofengland.nhs.uk
authors.forename: Srikanth
authors.initials: S
authors.lastname: Bellary